Skip to main content
. 2020 Oct 19;16(1):49–60. doi: 10.1007/s11739-020-02525-7

Table 2.

Criteria for identifying adult patients at risk for RFS

NICE [48] ASPEN 2020 [33] Friedli 2018 [21]
High risk in the presence of Moderate risk: 2 risk criteria needed Significant risk: 1 risk criteria needed Low risk: 1 minor risk factor High risk: 1 major or 2 minor risk factors Very high risk
One or more of the following: Two or more of the following: Minor risk factors Major risk factors
BMI  < 16 kg/m2  < 18.5 kg/m2 16–18.5 kg/m2  < 16 kg/m2  < 18.5 kg/m2  < 16 kg/m2  < 14 kg/m2
Weight loss  > 15% within the last 3–6 months  > 10% within the last 3–6 months 5% in 1 month 7.5% in 3 months or > 10% in 6 months  > 10% within the last 3–6 months  > 15% within the last 3–6 months  > 20%
Caloric intake Little or no nutritional intake > 10 days Little or no nutritional intake > 5 days

None or negligible oral intake for 5–6 days

OR

 < 75% of estimated energy requirement for > 7 days during an acute illness or injury

OR

 < 75% of estimated energy requirement for > 1 month

None or negligible oral intake for > 7 days

OR

 < 50% of estimated energy requirement for > 5 days during an acute illness or injury

OR

 < 50% of estimated energy requirement for > 1 month

Little or no nutritional intake > 5 days Little or no nutritional intake > 10 days Starvation > 15 days
Prefeeding potassium, phosphate, or magnesium serum concentrations Low levels Minimally low levels or normal current levels and recent low levels necessitating minimal or single‐dose supplementation Moderately/significantly low levels or minimally low or normal levels and recent low levels necessitating significant or multiple‐dose supplementation Low levels
Loss of subcutaneous fat Evidence of moderate loss Evidence of severe loss
Loss of muscle mass Evidence of mild or moderate loss Evidence of severe loss
Higher‐risk comorbidities* A history of alcohol abuse or drugs including insulin, chemotherapy, antacids, or diuretics Moderate disease Severe disease A history of alcohol abuse or drugs including insulin, chemotherapy, antacids, or diuretics

BMI body mass index

*Acquired immunodeficiency syndrome; Advanced neurologic impairment or general inability to communicate needs; Cancer; Chronic alcohol or drug use disorder; Dysphagia and esophageal dysmotility; Eating disorders; Food insecurity and homelessness; Failure to thrive, including physical and sexual abuse and victims of neglect; Hyperemesis gravidarum or protracted vomiting; Major stressors or surgery without nutrition for prolonged periods of time; Malabsorptive states (e.g., short‐bowel syndrome, Crohn’s disease, cystic fibrosis, pyloric stenosis, maldigestion, pancreatic insufficiency); Postbariatric surgery; Postoperative patients with complications; Prolonged fasting; Protein malnourishment; Refugees